Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Urinary Bladder Neoplasms 1Surgical Wound Infection 1Skin Neoplasms 1Neoplasms 1Leukemia, Myeloid, Acute 1Inflammation 1Infections 1Genetic Predisposition to Disease 1Breast Neoplasms 1

Interventions

Surveys and Questionnaires 3Interviews as Topic 3Specimen Handling 2Blood Specimen Collection 2posaconazole 1liposomal doxorubicin 1Vinorelbine 1Sequence Analysis, RNA 1Sequence Analysis, DNA 1Prophylactic Mastectomy 1Phlebotomy 1Mutation 1Multiparametric Magnetic Resonance Imaging 1Minoxidil 1Magnetic Resonance Spectroscopy 1High-Throughput Nucleotide Sequencing 1Genome-Wide Association Study 1Genetic Testing 1Fluconazole 1Exome 1Docetaxel 1Demography 1DNA 1Cognitive Behavioral Therapy 1Cephalexin 1Capecitabine 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Genetic Predisposition to Disease × Cephalexin × Clear all
NCT05020574 2026-03-18

Microbiome and Association With Implant Infections

University of California, San Francisco

Phase 2 Recruiting
200 enrolled
Breast

Breast Neoplasms, Genetic Predisposition to Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡